Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. - Wikidata - awgldk - TriplyDB

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.

http://www.wikidata.org/entity/Q42084495

about

High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II Self-interaction of soluble and surface-bound beta2-glycoprotein I and its enhancement by lupus anticoagulants Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids Interactions and molecular structure of cardiolipin and beta 2-glycoprotein 1 (beta 2-GP1)T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals Antiphospholipid antibodies associated with alcoholic liver disease specifically recognise oxidised phospholipids Both kinetic data and epitope mapping provide clues for understanding the anti-coagulant effect of five murine monoclonal antibodies to human beta2-glycoprotein I.Beta2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels.Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype.Do antibodies to beta2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.Further characterization of antibody and antigen in heparin-induced thrombocytopenia.Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome.Antiphospholipid antibodies: paradigm in transition.Antiphospholipid Antibodies and Associated Clinical Manifestations.Immunology of antiphospholipid antibodies and their interaction with plasma proteins.Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus.beta 2-Glycoprotein I: target antigen for autoantibodies in the 'antiphospholipid syndrome'.Non beta 2-glycoprotein I cofactors for antiphospholipid antibodies.Phospholipid binding plasma proteins required for antiphospholipid antibody detection--an overview.Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset.Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrin Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome.Prevalence of beta 2-glycoprotein I antibody in systemic lupus erythematosus patients with beta 2-glycoprotein I dependent antiphospholipid antibodies.Testing for and clinical significance of anticardiolipin antibodies Accelerated atheroma and anti-beta2-glycoprotein I antibodies.'Catastrophic' antiphospholipid syndrome.Autoantibodies associated with rheumatic diseases.Fluctuation in the Levels of Immunoglobulin M and Immunoglobulin G Antibodies for Cardiolipin and β2-Glycoprotein among Healthy Pregnant Women Investigation of antiphosphatidyl-serine antibody and antiphosphatidyl-inositol antibody in ischemic stroke patients Anti-beta 2-glycoprotein I autoantibodies and atherosclerosis.Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides Optimising testing for phospholipid antibodies.Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity.High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.Association of HLA-DM polymorphism with the production of antiphospholipid antibodies.Antiphospholipid antibody tests: spreading the net Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome.

P2860

Q22254095-63AF8B30-DEB5-4B8A-990E-3EDD2B80D194 Q24316919-0241BFF2-FEB0-449D-B7EA-E3BDC5E76B9D Q24561680-F10A5881-83E6-4AD6-BFE1-0858A737C5D7 Q24672569-240AAAAB-7BEB-4D12-ACBD-50BC005BE15E Q28143036-611C506A-1886-4C8F-9BE2-0D54313DB301 Q28364192-66E07DD5-696A-4101-BBD7-6D1004830B81 Q30580637-9EBA3527-7884-4B4B-B6EB-64666C304B6E Q33328443-7A78ABE1-6308-469F-945F-621582C12B0A Q33329907-CB720522-916D-418D-90F2-96AAF0816C72 Q33330002-6C2F3718-5F20-4418-AFAA-B1D6298D8446 Q33330540-C505838F-9A32-42BD-854D-8F0A144DAAC8 Q33330798-2D6E787A-87BA-434B-B6A2-B06149C58E10 Q33330858-74DE9416-17CD-4507-819C-E2103825C784 Q33382848-A352E46A-20C5-4FF0-82D9-5FEDD95998DD Q33433833-61CE0798-DEA6-4AF1-A46C-CE2F36904810 Q33496506-D6C6455F-9794-4638-85BA-17AF0C92E532 Q33496557-3C85807D-E1EA-44C5-96EC-B53F4D669221 Q33497587-FBE45EF8-6742-47D1-B84D-EF86A8075948 Q33497589-9ED65E37-7620-456E-A12D-1619D105ABFF Q33499192-142A7B72-3455-4907-8DCB-D3081E069FBE Q33502380-6A4526C1-E89B-4C59-9971-BA31B27308B1 Q33504706-C8F13D1A-143E-461A-9FEC-EB837D924DD6 Q33511345-EA1FB5C3-0DF0-4894-BC44-7248753E2434 Q33547975-B39B2EB1-F003-4D62-8C63-9C67B53199EE Q33566956-8B68FED7-E107-4828-95CB-8ECE6DFFD98B Q33766710-8495E140-A26B-4DCB-895F-9AD179AC6F69 Q33915467-4DB4757B-117C-4BED-BA3F-377140ADCCE9 Q34062864-8DA30235-8CC1-44AF-9DA9-001A4C5DBE7C Q34249566-A849AAE2-7FB1-4AA5-81D8-C4A623F940E5 Q34380569-FF79AC80-49F3-45ED-BFC9-A7699D830521 Q34442697-D15CE13F-EC5E-443E-AF08-21FBC3B8752F Q34790028-1C9C60B9-E34F-40EB-8B79-14ECAF39C38D Q35139987-00C7836B-3440-4866-A6A9-491C083BC11B Q35399567-921F5FBE-F816-4D82-8446-94C9A6AB2137 Q35552725-AC7A7EA9-7BDC-437B-B986-7A879AC3744B Q35553532-38C57875-CAE0-4D94-BE19-888F8125266F Q35553733-C27324BB-7CA2-4334-A731-7539C65887B2 Q35554909-2315C2EF-B509-481E-8DD7-016CBB274958 Q35555260-D5A6462E-2786-42C4-AA16-390D0FB4644B Q35584256-63435A01-B00A-4BE8-8811-B5E0AFB3DB7F

P2860

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.

http://www.wikidata.org/entity/Q42084495

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

1994年论文

@zh

1994年论文

@zh-cn

name

Anticardiolipin antibodies rec ...... modified solid phase surface.

@en

Anticardiolipin antibodies rec ...... modified solid phase surface.

@nl

type

label

Anticardiolipin antibodies rec ...... modified solid phase surface.

@en

Anticardiolipin antibodies rec ...... modified solid phase surface.

@nl

prefLabel

Anticardiolipin antibodies rec ...... modified solid phase surface.

@en

Anticardiolipin antibodies rec ...... modified solid phase surface.

@nl

P1433

Q42084495-4BE76A44-7A99-4E55-9F9C-C4C3C7C8E776

P1476

Q42084495-07F32F67-0666-4CF2-99CE-C93F3CFC4C59

P2093

Q42084495-21B00261-52D3-4B12-8207-92F99188E74A

Q42084495-4F0B44F5-1C7C-484D-8F15-5DE355780D58

Q42084495-AF1905B2-2BE9-4535-B1A0-5C49634557C0

P2860

Q42084495-1134FB25-B3D5-4D85-9633-9AAF00931300

Q42084495-1802B5F2-B168-47C8-B31D-B851C5E3FC17

Q42084495-1E6A0D28-4456-4431-9F86-663A28E7CFB8

Q42084495-3DF6F4D5-8491-4108-80E7-B009390A863D

Q42084495-470002FE-8C7F-4751-8C77-E61649E6095B

Q42084495-5C434AFA-CC97-42FE-8267-E49A529FCF1A

Q42084495-5F756D9E-2AA4-4602-A718-854AEEC7D348

Q42084495-6D18F7FA-CE81-4D3C-BFBA-9DEADEC6385D

Q42084495-954691D8-073D-42C8-A2A7-2F80AC6599E5

Q42084495-97BA20F7-3569-4ECB-BD68-088E27E5932A

P304

Q42084495-5302D67F-A832-4F14-8487-FCBE099792F5

P31

Q42084495-3E5F13DF-CA8A-4A28-8410-D2AFB401F0E6

P356

Q42084495-8758FF82-22C0-46FD-BB5B-78A851E100BD

P407

Q42084495-E0D46674-9AC1-476B-9678-C459666808AA

P433

Q42084495-BC51C88E-7FCB-4ACF-BD74-3F01E9E231C3

P478

Q42084495-A6F55ADC-2573-4164-875E-97FC21F8E4EF

P50

Q42084495-4872DEA8-31D3-4DA2-989A-594CBCD55A98

Q42084495-C5BA749E-29BC-440E-B972-DBA1244FE27D

P577

Q42084495-0ECC318C-41F5-406B-91E4-3EE88838C6F6

P5875

Q42084495-7F136AEF-D857-4989-A065-B08E776B0D02

P698

Q42084495-4ACCF227-C031-4C3F-BCD6-93963B616A12

P921

Q42084495-460570F4-DEC3-4568-969E-F81EC70205D1

P932

Q42084495-6F06E11C-8695-4A09-98FE-61C3B960CBB2

P356

P1433

Journal of Experimental Medicine

P1476

Anticardiolipin antibodies rec ...... modified solid phase surface.

@en

P2093

Igarashi Y

http://www.w3.org/2001/XMLSchema#string

Triplett DA

http://www.w3.org/2001/XMLSchema#string

Yasuda T

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor

Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus

Phosphorus assay in column chromatography

Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome.

Immunology and clinical importance of antiphospholipid antibodies.

Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.

Anti-phospholipid antibodies.

P304

457-462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.179.2.457

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

179

http://www.w3.org/2001/XMLSchema#string

P50

P577

1994-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276943617

http://www.w3.org/2001/XMLSchema#string

P698

7507506

http://www.w3.org/2001/XMLSchema#string

P921

P932

2191370

http://www.w3.org/2001/XMLSchema#string